NCT03375775
Evaluation of Subcutaneous Immunotherapy Towards Pollen in Children No drug interventions other Not Available completed NCT02555761
Safety and Efficacy of Lastacaft® for the Prevention of Itching Associated With Allergic Conjunctivitis in Korea Not Available Not Available completed NCT01258309
Safety and Efficacy of Olopatadine Hydrochloride/Ketorolac Tromethamine Ophthalmic Solution Compared With Olopatadine Hydrochloride Ophthalmic Solution in Patients With Seasonal Allergic Conjunctivitis treatment 3 completed NCT00655109
A Comparison of Olopatadine and Fluticasone in Patients With Allergic Conjunctivitis treatment 4 completed NCT00424398
Evaluation of the Onset and Duration of Action of Bepotastine Besilate Ophthalmic Solution in Acute Allergic Conjunctivitis treatment 2 / 3 completed NCT00422149
Twin SUBLIVAC® Grasses Clinical Efficacy Study No drug interventions treatment 3 completed NCT04299399
Corneal Biomechanical Changes of Allergic Conjunctivitis No drug interventions Not Available Not Available unknown_status NCT03709121
A Methodology Development Clinical Trial of Reproxalap in Subjects With Seasonal Allergic Conjunctivitis Using the Environmental Exposure Chamber treatment 1 / 2 completed NCT02161146
AGN-229666 Ophthalmic Solution in Japanese Patients With Allergic Conjunctivitis prevention 3 completed NCT01987765
Safety and Efficacy of Relestat Ophthalmic Solution 0.05% for Allergic Conjunctivitis in Korea Not Available Not Available completed NCT01289431
Mapracorat Ophthalmic Formulation in Subjects With Allergic Conjunctivitis prevention 2 completed NCT00917488
Glycyphagus Domesticus Allergen Extract. Determination of the in Vivo Biological Activity in Histamine Equivalent Units (HEP). No drug interventions diagnostic 2 completed NCT00718744
Standardization of Chortoglyphus Arcuatus Allergenic Extract. Determination of Biological Activity in HEP Units No drug interventions Not Available 2 completed NCT00501527
Immunotherapy With Depigmented and Polymerized Allergen Extract of Phleum Pratense No drug interventions treatment 2 completed NCT06063044
Food-specific IgG4-guided Elimination Diets Improve Allergy Symptoms in Children No drug interventions Not Available Not Available completed NCT03186755
Clinical Evaluation of Hylo-Dual Versus Patanol in Children With Seasonal Allergic Conjunctivitis treatment 4 recruiting NCT03012165
A Study of ADX-102 in Subjects With Allergic Conjunctivitis treatment 2 completed NCT02082262
AGN-229666 Ophthalmic Solution for the Treatment of Seasonal or Perennial Allergic Conjunctivitis No drug interventions treatment 3 completed NCT01732757
A Study to Evaluate the Efficacy of Lastacaft® Compared to Pataday™ and Placebo in Patients With Acute Allergic Conjunctivitis treatment 4 completed NCT01541904
Efficacy and Safety of PRO-118 Ophthalmic Solution in Allergic Conjunctivitis No drug interventions treatment 2 withdrawn NCT01470118
A Study to Evaluate the Duration of LASTACAFT® in Acute Allergic Conjunctivitis treatment 4 completed NCT00311844
A Study of the Effects of Desloratadine on Conjunctival Allergen Challenge-induced Ocular Signs and Symptoms (Study P04209) treatment 4 completed NCT00586664
Efficacy and Safety Study of Bepotastine Besilate Ophthalmic Solution in Allergic Conjunctivitis treatment 3 completed NCT01561521
An Evaluation of the Onset and Duration of Action of AKF-1 Ophthalmic Solution in Treating Acute Allergic Conjunctivitis No drug interventions treatment 3 completed NCT01037179
An Open-Label, Long-Term Study With AL-4943A Ophthalmic Solution, 0.2% in Patients With Allergic Conjunctivitis treatment 3 completed NCT00882687
Efficacy Study to Evaluate the Effectiveness of 3 Concentrations of SAR 1118 in Allergic Conjunctivitis prevention 2 completed NCT01119287
Assessing the Efficacy of Maxidex® and Patanol® for the Treatment of Allergic Conjunctivitis diagnostic 4 completed NCT03862053
Manuka Eye Droops for Treatment of Allergy treatment 4 withdrawn NCT00569777
Safety Study of a Contact Lens With Ketotifen in Healthy, Normal Volunteers No drug interventions basic_science 3 completed NCT04622345
Safety and Efficacy of VSJ-110 in the Treatment of Allergic Conjunctivitis in Adults With a History of Ocular Allergies No drug interventions treatment 2 completed NCT02978183
Evaluation of the Effectiveness of ST266 Ophthalmic Drops Compared to Placebo to Treat Allergic Conjunctivitis treatment 2 completed NCT01134328
Efficacy of AC-150 for the Treatment of Allergic Conjunctivitis in the Enviro-CAC™ Model No drug interventions treatment 2 completed NCT00609128
Effect of Olopatadine on Allergic Tear Mediators basic_science Not Available completed NCT03038971
Study Evaluating Safety of Ragweed Mix Given by Intralymphatic Node Injections No drug interventions treatment 1 terminated NCT03660878
A Methodology Development Environmental Clinical Trial of Reproxalap in Subjects With Seasonal Allergic Conjunctivitis treatment 1 / 2 completed NCT00689078
Evaluation of the Efficacy of Topical Ophthalmic Steroids in a Modified Conjunctival Allergen Challenge (CAC) Model treatment 4 completed NCT01332188
Efficacy of AC-170 for the Treatment of Allergic Conjunctivitis in the Conjunctival Allergen Challenge (CAC) Model No drug interventions treatment 2 / 3 completed NCT03479307
A Study Evaluating Bilastine Ophthalmic Solution 0.6% in the Conjunctival Allergen Challenge (Ora-CAC®) Model. treatment 3 completed NCT01339507
A Patient Reported Ocular Comfort Assessment Comparing Bepreve to Lastacaft No drug interventions Not Available Not Available completed NCT01109485
Clinical Evaluation of 0.1% Olopatadine Hydrochloride Ophthalmic Solution in Pediatric Patients treatment 4 completed NCT00836485
Evaluation of the Safety and Efficacy of Ketotifen 4.0% Patch as Compared to Placebo Patch, Olopatadine 0.2% Ophthalmic Solution, and Artificial Tears in the Conjunctival Allergen Challenge (CAC) Model of Acute Allergic Conjunctivitis treatment 2 completed NCT01159015
Study Evaluating the Safety of KetoNaph Ophthalmic Solution in Healthy Volunteers No drug interventions screening 3 completed NCT00298337
Use of Probiotic Bacteria in Prevention of Allergic Disease in Children 1999-2008 prevention 2 / 3 unknown_status NCT01120132
Study Evaluating the Efficacy of Administration of Cyclosporine (Low Dose and High Dose) and Prednisolone Acetate Compared to Its Components and Vehicle in Patients With Allergic Conjunctivitis treatment 2 completed NCT01012752
A Multicenter Study to Evaluate Safety and Efficacy of Specific Immunotherapy With Modified Allergen Extracts No drug interventions treatment 3 unknown_status NCT05824000
PMCF Study to Evaluate Performance and Safety of "Optrex Double Action Soothing and Lubricating Drops" No drug interventions treatment Not Available completed NCT01363700
Study of DE-114 Ophthalmic Solution in Patients With Allergic Conjunctivitis Not Available 3 completed NCT01443442
Bepreve vs. Alrex in Subjects With Moderate to Severe Allergic Conjunctivitis treatment 4 completed NCT01685242
A Single-Center,Evaluation of the Onset and Duration of Action of AC-170 0.24% Compared to Vehicle No drug interventions treatment 3 completed NCT02082899
A Single Center Study for the Treatment of Moderate to Severe Allergic Conjunctivitis (EBI-005-AC-1) treatment 2 completed NCT01731249
Efficacy and Safety Study of a Sublingual Immunotherapy Solution to Treat Patients Suffering From Birch Pollen Allergic Rhinoconjunctivitis No drug interventions treatment 3 completed NCT02079649
Safety and Efficacy Study of AL-53817 and AL-78843 Ophthalmic Solutions for Allergic Conjunctivitis treatment 2 completed NCT01363713
A Long-term Study of DE-114 Ophthalmic Solution in Patients With Allergic Conjunctivitis No drug interventions Not Available 3 completed NCT02251613
Effectiveness of Olopatadine HCl Ophthalmic Solution for the Treatment of Allergic Conjunctivitis in Japan treatment 4 completed NCT06459219
Factors Determining Tolerance to Nasal Allergen Exposure With Advanced Age in a Subset of Birch Pollen Allergic Subjects No drug interventions Not Available Not Available not_yet_recruiting NCT04619017
Airway Immune Response to Allergens (Use Lay Language Here) No drug interventions basic_science 1 active_not_recruiting NCT03320434
Study Evaluating the Efficacy and Safety of PRT-2761 for the Treatment of Acute and Chronic Allergic Conjunctivitis treatment 2 completed NCT00375596
A Study Of The Safety And Effectiveness Of A New Treatment For Allergic Conjunctivitis Not Available 2 withdrawn NCT00586625
Safety Study for Bepotastine Besilate Ophthalmic Solution in Normal Volunteers treatment 3 completed NCT00889330
Safety and Efficacy Study of a Eye Drop for Eye Allergy treatment 3 completed NCT04641130
Clinical Validation Study in Allergic Conjunctivitis to Birch Pollen During Allergen Challenge in ALYATEC EEC No drug interventions other Not Available completed NCT04050865
A Study Evaluating the Safety and Efficacy of OTX-DP for the Treatment of Allergic Conjunctivitis treatment 3 completed NCT01479374
Efficacy and Safety of AL-4943A Ophthalmic Solution in Patients With Allergic Conjunctivitis Using the Conjunctival Allergen Challenge (CAC) Model treatment 3 completed NCT00364091
Evaluation of Efficacy of Ophthalmic Solution in Seasonal Allergic Conjunctivitis treatment 3 completed NCT01001091
AL-38583 Ophthalmic Solution for Allergic Conjunctivitis Associated Inflammation treatment 2 completed NCT01878929
The Effect of Pollen Season on Subcutaneous Allergen Immunotherapy Reactions No drug interventions treatment 1 / 2 unknown_status NCT02148744
Safety and Tolerability of XmAb®7195 in Adult Healthy Volunteers and Adult Subjects With a History of Allergic Rhinitis and/or Allergic Conjunctivitis and/or Atopic Dermatitis No drug interventions treatment 1 completed NCT01203540
Evaluation of the Effect and Tolerance of Preservative Free NAAGA on the Inflammatory Component and Symptoms of Dry Eye Syndrome in Allergic Conjunctivitis Patients treatment 4 completed NCT02308501
A Single-Center Evaluation of the Anti-Inflammatory Effects of Lastacaft as Measured by In-Vivo Confocal Microscopy treatment 4 completed NCT03494504
ALLEVIATE Trial - A Phase 3 Trial in Subjects With Allergic Conjunctivitis treatment 3 completed NCT00987272
Study of Olopatadine HCl Ophthalmic Solutions Compared to Vehicle Using the Conjunctival Allergen Challenge (CAC) Model of Acute Allergic Conjunctivitis in Japanese Subjects treatment 3 completed NCT01697969
Confocal Analysis of Corneal Structures of Symptomatic Allergic Conjunctivitis Patients Not Available 4 completed NCT01294969
Patient Perception Study for AL-4943A treatment 4 completed NCT01159769
Patient Perceptions and Quality of Life Associated With the Use of Olapatadine 0.2% for the Treatment of Allergic Conjunctivitis treatment 4 completed NCT00559546
Montelukast as a Controller of Atopic Syndrome treatment 4 completed NCT04532710
Therapeutic Effect of Tacrosolv in Patients With Allergic Rhinoconjunctivitis No drug interventions treatment 2 completed NCT04695795
Sea Water in Allergic Conjunctivitis No drug interventions Not Available Not Available unknown_status NCT01698814
A Six-Week Safety Study of an Investigational Ophthalmic Solution Not Available 3 completed NCT05839938
The Role of Vitamin D in Corneal Epithelial Barrier Function, Ocular Microbiome, Ocular Inflammation, and Visual Acuity of Children With Allergic Conjunctivitis No drug interventions treatment Not Available enrolling_by_invitation NCT01282138
Assessment of Alcon's Ocular Image Quantification System diagnostic 4 completed NCT00244543
Evaluation of Efficacy of Ophthalmic Solution in Induced Allergic Conjunctivitis treatment 3 completed NCT04810390
Study to Assess the Safety, Tolerability and Efficacy of Bilastine Ophthalmic Solution 0.6% in Children treatment 3 completed NCT01860664
Hydrocortisone Ophthalmic Ointment 0.5% for Treatment of Allergic Conjunctivitis treatment 2 terminated NCT05314621
A Study Comparing the Efficacy of Pataday® Once Daily Relief Extra Strength to Flonase® Allergy Relief in Subjects With Allergic Conjunctivitis treatment 4 completed NCT01471184
The Effects of Ectoin® Allergy Nasal Spray and Ectoin® Allergy Eye Drops Compared to Placebo No drug interventions prevention 1 completed NCT00574379
Efficacy, Safety and PK of Once or Twice Daily Bilastine (10 or 20 mg) Compared With Placebo in the Symptomatic Treatment of SAR treatment 2 completed NCT00770133
Ketotifen/Naphazoline Ophthalmic Solution in the Conjunctival Allergen Challenge Model of Acute Allergic Conjunctivitis. treatment 3 completed NCT05234554
The INVIGORATE 2 Trial: A Clinical Trial to Assess the Efficacy and Safety of Subjects With Seasonal Allergic Conjunctivitis treatment 3 completed NCT03820154
Diagnostic Equivalence of the Skin Prick Test Tape vs. Conventional Skin PrickTest No drug interventions diagnostic Not Available unknown_status NCT01320553
Effect of Different Concentrations of SPARC1102 on Allergic Conjunctivitis No drug interventions treatment 2 completed NCT00276445
Alleviation of Cedar Pollen Induced Allergic Symptoms by Orally Taken Superfine Beta-1,3-Glucan prevention 4 terminated NCT00489398
Comparison of CL Wear Between Two Allergy Drops treatment 4 withdrawn NCT00443105
Topical Tacrolimus 0.03% Ointment for Intractable Allergic Conjunctivitis: An Open Label Pilot Study treatment 2 unknown_status NCT01107405
Loteprednol Ophthalmic Base Compared to Loteprednol Ophthalmic Suspension vs Placebo in an Allergen Challenge prevention 2 completed NCT01275105
A Single-Center, Randomized, Double-Masked, Placebo and Active Controlled, Dose-Ranging Evaluation of the Duration of Action of Brimonidine Tartrate Ophthalmic Solution in the Control of Ocular Redness Induced by Conjunctival Allergen Challenge (CAC) prevention 2 completed NCT00818805
Efficacy Investigation Study of Olopatadine Hydrochloride Ophthalmic Solution Using OHIO Chamber in Patients With Seasonal Allergic Rhinitis (SAR) treatment 4 completed NCT01390961
Comparison of Tolerability Between Two Allergy Drops treatment 4 unknown_status NCT01346371
The Effect of BEPREVE 1.5% on Tear Film Osmolarity and Tear Film Lipid Layer treatment 4 completed NCT00423007
Efficacy and Safety of Topical Bromfenac Ophthalmic Solution vs. Placebo in Subjects With Allergic Conjunctivitis treatment 3 completed NCT01551056
A Multi-Center Study Evaluating the Onset and Duration of Action of AC-170 0.24% Compared to Vehicle in the Conjunctival Allergen Challenge (CAC) No drug interventions treatment 3 completed NCT01439815
An Allergen BioCube (ABC) Study Evaluating the Efficacy of Fluticasone Propionate Nasal Spray Compared to Placebo prevention 4 completed NCT01679015
Evaluating Patients With Eye Allergies and Determining if There Are Also Dry Eyes No drug interventions Not Available Not Available completed NCT00889252
Safety Study of a Contact Lens With Ketotifen in Healthy, Normal Volunteers No drug interventions treatment 3 completed NCT03812952
China Red Eye Study on Allergic Conjunctivitis No drug interventions Not Available Not Available unknown_status NCT00331500
Olopatadine 0.2% for the Treatment of Allergic Conjunctivitis treatment 3 completed NCT06153342
A Study of TL-925 for the Treatment of Allergic Conjunctivitis No drug interventions treatment 2 recruiting NCT05829499
PMCF Study to Evaluate Performance and Safety of "Xanoftal Next" No drug interventions treatment Not Available completed NCT04207736
The INVIGORATE Trial: A Clinical Trial to Assess the Efficacy and Safety of Subjects With Seasonal Allergic Conjunctivitis. treatment 3 completed NCT05969236
A Study of MDI-1228_mesylate Ophthalmic Solution in Healthy Adults No drug interventions treatment 1 completed NCT01881113
A Multi-Center, Evaluation of the Onset and Duration of Action of AC-170 0.24% Compared to Vehicle No drug interventions treatment 3 completed NCT03101618
Animal Allergy in Korean Pet Owners, Pet-related Industry Workers, and Laboratory Animal Reseachers No drug interventions Not Available Not Available completed NCT00241319
Evaluation of Efficacy of Ophthalmic Solution in Induced Acute Allergic Conjunctivitis treatment 3 completed NCT03489941
A Single-Center Evaluation of the Relative Efficacy of EM-100 Compared to Zaditor® (Ketotifen Fumarate Ophthalmic Solution 0.035%) and Vehicle treatment 3 completed NCT04389034
Influence of Specific Immunotherapy With Pollinex Quattro (Tree-/Grass Pollen) on Allergen-specific Immunoglobulin E (IgE) Levels No drug interventions Not Available Not Available completed NCT02322216
Olopatadine Hydrochloride Ophthalmic Solution Study in Chinese Subjects treatment 3 completed NCT04776096
Efficacy and Toxicity of Bepotastine 1,5% PF vs Olopatadine 0,2% With BAK on Allergic Conjunctivitis Treatment treatment 4 completed NCT01326858
Safety and Comfort of AL-4943A Ophthalmic Solution Not Available 1 completed NCT00775658
Olopatadine Eye Drops and Allergy Skin Testing diagnostic Not Available completed NCT05815758
Evaluation of the Safety and Pharmacokinetics of Brimonidine Tartrate 0.025%/Ketotifen Fumarate 0.035% Combination Ophthalmic Solution Not Available Not Available completed NCT00982163
A Single-Center Evaluation of the Pattern of Allergic Signs and Symptoms During 4 Weeks in Ragweed Season No drug interventions Not Available Not Available completed NCT00769886
Ketotifen/Naphazoline Ophthalmic Solution in the Conjunctival Allergen Challenge Model of Allergic Conjunctivitis. treatment 3 completed NCT03368339
Effectiveness of PR013 Topical Ophthalmic Drops Compared to Vehicle for the Treatment of Allergic Conjunctivitis No drug interventions treatment 2 completed NCT00389025
Mast-Cell Stabilizing Effects of Olopatadine prevention 4 completed NCT05186025
Tyrosine Allergoid Paediatric and Adult Study No drug interventions Not Available Not Available active_not_recruiting NCT05579730
Evaluation of Brimonidine Tartrate/Ketotifen Fumarate Combination for the Treatment of Allergic Conjunctivitis treatment 3 completed NCT01686048
The Significance of Ambrosia in Allergic Rhinitis and Asthma in Israel No drug interventions Not Available Not Available completed NCT03755557
Demonstration of Equivalence and Early Onset of a Novel Anti-allergic Nasal Spray Compared to Marketed Nasal Spray treatment 3 completed NCT01337557
Use of BEPREVE (Bepotastine Besilate Ophthalmic Solution) 1.5% for Allergic Conjunctivitis and Contact Lenses treatment 4 unknown_status NCT00432757
Evaluation of Efficacy and Safety of an Anti-Allergy Drug With a Contact Lens in Allergic Conjunctivitis treatment 3 completed NCT01754766
AGN-229666 for the Treatment of Allergic Conjunctivitis No drug interventions treatment 2 completed NCT03682965
Texan Allergy & Sinus Center Mountain Cedar Intra-Lymphatic Immunotherapy Study No drug interventions treatment 2 completed NCT00445874
Evaluation of Efficacy and Safety of an Anti-Allergy Drug With a Contact Lens in the Treatment of Allergic Conjunctivitis Not Available 3 completed NCT06293820
A Study Of TL-925 For The Treatment of AC No drug interventions treatment 2 completed NCT00881673
To Evaluate the Efficacy of AL-38583 in the Reduction of Tear Eosinophil Count Following Conjunctival Allergen Challenge treatment 2 withdrawn NCT01743027
Efficacy and Safety of an Ophthalmic Solution in Patients With Allergic Conjunctivitis treatment 3 completed NCT00534794
Study of Two Marketed Ocular Anti-Allergy Medications in Subjects With Allergic Conjunctivitis treatment 4 completed NCT03627689
Molekule for Allergic Rhinitis/Asthma No drug interventions prevention Not Available terminated NCT01272089
A Study of Patient Perception and Quality of Life Associated With the Use of Olopatadine 0.2% in Subjects With Allergic Conjunctivitis treatment 4 completed NCT04198740
Proteomic and Metabolomic Lacrimal Fingerprint in Diverse Pathologies of the Ocular Surface No drug interventions Not Available Not Available recruiting NCT01657240
Clinical Efficacy of PRO-118 Compared With Olopatadine Hydrochloride Ophthalmic Solution in Allergic Conjunctivitis treatment 3 withdrawn NCT01808768
Ocular Allergy Treatment Practical Impact Trial treatment 4 unknown_status NCT03231969
A Single-Center, Phase 2 Study Evaluating Bilastine Ophthalmic Solution in the CAC® Model treatment 2 completed NCT01639846
Evaluation of the Onset and Duration of Action of RX-10045 in Allergic Conjunctivitis No drug interventions treatment 2 completed NCT03861910
Dietary Choice for the Management of Cow's Milk Allergy Influences Other Allergic Manifestations No drug interventions Not Available Not Available completed NCT05265910
A Study Comparing the Efficacy of Pataday® Once Daily Relief Extra Strength to Claritin® Tablets 24-Hour in Subjects With Allergic Conjunctivitis treatment 4 completed NCT00833495
Evaluation of Efficacy of Coadministration of FOV1101-00 and Prednisolone Acetate in Patients With Mild Ongoing Ocular Allergic Inflammation treatment 2 completed NCT01534195
Evaluation of the Efficacy of Topical Ophthalmic Steroids in a Modified Conjunctival Allergen Challenge (CAC) Model prevention 4 completed NCT02578914
A Safety and Activity Study of NS2 in Subjects With Allergic Conjunctivitis No drug interventions treatment 2 completed NCT01174823
Safety and Efficacy of Bepotastine Besilate Ophthalmic Solution in Seasonal Allergic Conjunctivitis Patients treatment 2 completed NCT02492321
A Multi-Center Environmental Study for the Treatment of Moderate to Severe Ocular Allergic Conjunctivitis treatment 3 completed